1. Home
  2. TG vs ORGO Comparison

TG vs ORGO Comparison

Compare TG & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.89

Market Cap

262.4M

Sector

Industrials

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$1.81

Market Cap

239.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TG
ORGO
Founded
1988
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.4M
239.3M
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
TG
ORGO
Price
$7.89
$1.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
157.8K
878.3K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
151.06
1600.00
EPS
0.34
N/A
Revenue
$800,821,000.00
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$26.27
P/E Ratio
$23.47
N/A
Revenue Growth
8.29
17.04
52 Week Low
$6.25
$1.54
52 Week High
$10.53
$7.08

Technical Indicators

Market Signals
Indicator
TG
ORGO
Relative Strength Index (RSI) 51.29 28.03
Support Level $7.24 $1.54
Resistance Level $8.20 $2.64
Average True Range (ATR) 0.36 0.13
MACD 0.04 -0.07
Stochastic Oscillator 31.84 23.00

Price Performance

Historical Comparison
TG
ORGO

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: